The number of people with susceptibility test result for rifampicin in Belarus
Belarus: The number of people with susceptibility test result for rifampicin was 1,032 in 2021. ▼ Falling
Latest (2021)
1,032
Change on year
up 1.7%
World rank
66th
of 155 countries
All-time high
1,690
in 2017
All-time low
1,015
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Belarus, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Belarus stood at 1,032.
Compared with earlier readings it is up 1.7% on the previous year and down 38.9% over five years.
That places Belarus 66th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Belarus, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 1,690 | — |
| 2018 | 1,529 | -9.5% |
| 2019 | 1,490 | -2.6% |
| 2020 | 1,015 | -31.9% |
| 2021 | 1,032 | +1.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,570 | 1,490 | 1,690 | 3 |
| 2020s | 1,024 | 1,015 | 1,032 | 2 |
Countries ranked near Belarus
More health data for Belarus
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3867 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,674 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.57 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.019 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.56 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Belarus?
- The number of people with susceptibility test result for rifampicin in Belarus was 1,032 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Belarus?
- The highest recorded value was 1,690 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Belarus?
- The lowest recorded value was 1,015 in 2020.
- How does Belarus rank for the number of people with susceptibility test result for rifampicin?
- Belarus ranks 66th out of 155 countries with data for 2021.
- Where does this Belarus data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).